Transplant rejection - PDFSEARCH.IO - Document Search Engine

Transplant rejection
Results: 206

#	Item
71	Out of body experience for stem cells may lead to more successful transplants Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-02-25 14:50:59 Transplantation medicine Biotechnology Cell biology Immunology Hematopoietic stem cell Stem cell Allotransplantation Transplant rejection Haematopoiesis Biology Medicine Stem cells
72	MEDICATION GUIDE ZORTRESS (ZOR-tres) (everolimus) Tablets Read this Medication Guide before you start using ZORTRESS and each time you get a refill. There may be new information. This information does not take the place Add to Reading List Source URL: www.pharma.us.novartis.com Language: English - Date: 2015-01-30 14:53:55 Macrolides Kidney transplantation Transplantation medicine Organ transplantation Transplant rejection Sirolimus BK virus Tacrolimus Liver transplantation Medicine Organ transplants Immunosuppressants
73	T2005[removed]Simulect® (basiliximab) Add to Reading List Source URL: www.pharma.us.novartis.com Language: English - Date: 2014-07-11 06:14:52 Prodrugs Azathioprine Nitroimidazoles Purines Mycophenolic acid Immunosuppressive drug Basiliximab Kidney transplantation Transplant rejection Medicine Immunosuppressants Organ transplants
74	An interferon-free antiviral regimen for HCV after liver transplantation New England Journal of Medicine, [removed]Hepatitis C virus (HCV) infection is the leading indication for liver transplantation worldwide, and in Add to Reading List Source URL: www.hepcassoc.org Language: English - Date: 2014-11-21 12:59:21 Hepatitis Hepatitis C Ribavirin Interferon Liver transplantation Transplant rejection Hepatitis C and HIV co-infection Boceprevir Medicine Antivirals Protease inhibitors
75	achanA September 12, 2007 Astellas Initiates Phase II Clinical Trials for Immunosuppressant, ASP0485 Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 20:52:49 Tacrolimus Alefacept Health Psoriasis Transplant rejection Immunosuppressants Medicine Astellas Pharma
76	May 7, 2008 Astellas Receives an Approvable Letter for an Immunosuppressant FK506 Modified Release Formulation in the U.S. Japan, May 7, [removed]Astellas Pharma Inc. (headquarters: Tokyo, President and CEO: Masafumi Nogi Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-17 23:59:47 Immunology Immunosuppressants Macrolides Tacrolimus Astellas Pharma Kidney transplantation Organ transplantation Transplant rejection Allotransplantation Medicine Transplantation medicine Organ transplants
77	March 14, 2008 Astellas Receives an Approvable Letter for Their Immunosuppressant FK506 Modified Release Formulation in the U.S. Japan, March 14, [removed]Astellas Pharma Inc. (headquarters: Tokyo, President and CEO: Masa Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 00:05:39 Tacrolimus Astellas Pharma Kidney transplantation Transplant rejection Medicine Immunosuppressants Macrolides
78	PDF Document Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:20:54 Macrolides Tacrolimus Astellas Pharma Organ transplants Transplantation medicine Immunosuppressive drug Organ transplantation Transplant rejection Immunosuppression Medicine Immunology Immunosuppressants
79	March 20, 2007 Astellas Receives an FDA Action Letter for Prograf sNDA Japan, March 20, [removed]Astellas Pharma Inc. (headquarters: Tokyo, president and CEO: Masafumi Nogimori) today announced that its US subsidiary, Ast Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:34:04 Tacrolimus Kidney transplantation Astellas Pharma Mycophenolic acid Transplant rejection Immunosuppression Heart transplantation Liver transplantation Ciclosporin Medicine Immunosuppressants Organ transplants
80	May 30, 2006 Application for the immunosuppressant FK506 Modified Release Formulation in Japan Japan, May 30, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Toichi Takenaka) today a Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-19 00:58:14 Immunosuppressants Macrolides Tacrolimus Astellas Pharma Graft-versus-host disease Transplant rejection Medicine Transplantation medicine Health

UPDATE